It has been recognized for >50 years that cytochrome
b
5
(
b
5
) stimulates some cytochrome P450 (P450)–catalyzed oxidations, but the basis of this function is still not understood well. The strongest stimulation of catalytic activity by
b
5
is in the P450 17A1 lyase reaction, an essential step in androgen synthesis from 21-carbon (C21) steroids, making this an excellent model system to interrogate
b
5
function. One of the issues in studying
b
5
–P450 interactions has been the limited solution assay methods. We constructed a fluorescently labeled variant of human
b
5
that can be used in titrations. The labeled
b
5
bound to WT P450 17A1 with a
K
d
of 2.5 nM and rapid kinetics, on the order of 1 s
−1
. Only weak binding was observed with the clinical P450 17A1 variants E305G, R347H, and R358Q; these mutants are deficient in lyase activity, which has been hypothesized to be due to attenuated
b
5
binding.
K
d
values were not affected by the presence of P450 17A1 substrates. A peptide containing the P450 17A1 Arg-347/Arg-358 region attenuated Alexa 488-T70C-
b
5
fluorescence at higher concentrations. The addition of NADPH–P450 reductase (POR) to an Alexa 488-T70C-
b
5
:P450 17A1 complex resulted in a concentration-dependent partial restoration of
b
5
fluorescence, indicative of a ternary P450:
b
5
:POR complex, which was also supported by gel filtration experiments. Overall, these results are interpreted in the context of a dynamic and tight P450 17A1:
b
5
complex that also binds POR to form a catalytically competent ternary complex, and variants that disrupt this interaction have low catalytic activity.